OpenAI Researcher Miles Wang Launches AI Drug Discovery Startup, Raising $200M at $2B Valuation

According to TechCrunch, OpenAI researcher Miles Wang is founding an AI-focused biotech startup for drug discovery, raising approximately $200 million at a $2 billion valuation. Lightspeed Venture Partners may lead the funding round.

The startup plans to develop AI models for identifying new applications for existing drugs and failed clinical candidates, with multiple OpenAI researchers expected to join the venture.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments